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1. Introduction
123I-iodoamphetamine (IMP) single photon emission computed tomography (SPECT) is used
to evaluate the cerebral blood flow (CBF) in patients with either cerebrovascular or neurode‐
generative diseases [3, 6]. However, its application for patients with brain tumors has so far
only been rarely reported [2, 8, 11]. Primary central nervous system lymphoma (PCNSL) is a
rare tumor that shows a delayed IMP uptake [1, 5, 7, 9, 10]. The relatively low spatial resolution
of SPECT is a clinical problem when it is used to diagnose brain tumors.
Anatomical standardized statistical mapping is a useful method for improving the diagnostic
ability of SPECT. We examined the statistical mapping of IMP SPECT in patients with brain
lesions. In this report, we analyzed the diagnostic performance of the usual reconstructed
images and statistical mapping of IMP SPECT of patients with brain tumors.
2. Patients and methods
This study included IMP SPECT images for 49 patients with brain lesions: 20 with PCNSL, one
with Burkitt’s lymphoma, 15 with glioma, two with meningioma, one with a metastatic tumor,
two with multiple sclerosis (MS), five with cerebritis and three without any pathological
diagnosis, but a clinical diagnosis of PCNSL. No patients had received prior radiation or
chemotherapy for brain tumors. Three patients had previously received steroid medication at
the time of IMP SPECT examination.
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We examined the normal reconstructed images and statistical mapping of IMP SPECT. After
the intravenous injection of 222 Megabecquerel (MBq) of 123I-IMP, the early (15 minutes) and
delayed (3 hours) images were acquired using a multi-detector SPECT machine (E.CAM,
Siemens Medical, Erlangen, Germany) and a high resolution collimator (LEHR, Siemens
Medical, Erlangen, Germany). The Butterworth pre-correction filter and the Chang method
were used for pre- and post-attenuation corrections. The Ramp filter was used for reconstruc‐
tion. The image matrices, the pixel sizes and the slice thickness of the IMP SPECT were 128 x
128, 3.31 mm and 6.62 mm, respectively. All SPECT data were saved in the Digital Imaging
and Communication in Medicine (DICOM) format. The DICOM data were transferred to a
newly developed software program, the iNeurostat+ (Nihon Medi-physics, Hyogo, Japan),
which runs on a Windows personal computer. The SPECT data were anatomically standar‐
dized on normal brain images. The increased uptakes of IMP were statistically mapped on the
tomographic images of the normal brain. The image quality, diagnostic ability and imaging
artifacts were evaluated by a visual inspection (Figure 1).
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Figure 1. Automatic Process Flow of iNeurostat+
Magnetic resonance imaging (MRI) data were acquired with 1.5 Tesla instrument (Gyroscan
NT Intera, Philips, Amsterdam, The Netherlands). The tumor diameters and size were
measured using gadolinium-diethyltriaminepentaacetic acid (Gd-DTPA)-enhanced T1-
weighted MRI.
Tumors of the Central Nervous System – Primary and Secondary96
The statistical analysis was performed with the Chi-square test. Values of p < 0.05 were
considered to be significant.
3. Representative cases
3.1. Case 1 (Figure 2)
A 58-year-old female had a Gd-enhanced MRI scan, which showed a homogenously enhanced
tumor at the left putamen. Delayed IMP SPECT showed tumor uptake, however, other normal
brain uptake was also detected. Statistical mapping of IMP SPECT data demonstrated hot
tumor uptake and no uptake into the normal brain. A tumor biopsy revealed a pathological
diagnosis of PCNSL.
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Figure 2. 58 Woman: PCNSL
3.2. Case 2 (Figure 3)
A 71-year-old female underwent a Gd-enhanced MRI scan, which showed a homogeneously
enhanced tumor at the left cerebellum. Delayed IMP SPECT did not show clear uptake into
the cerebellar lesion. Statistical mapping of IMP SPECT demonstrated clear uptake of IMP into
the tumor. The tumor was pathologically diagnosed as PCNSL by biopsy.
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4. Results
Eighteen patients showed a high uptake in the delayed IMP SPECT images (16 PCNSL, two
unknown). All unknown patients were successfully treated with steroids and radiation
therapy, so their clinical diagnosis was PCNSL. Other tumors or lesions did not show a high
uptake on delayed IMP SPECT, so there were no false positives (Table 1). Four patients with
pathologically proven PCNSL showed no uptake in the original IMP SPECT. These tumors
were either too small to detect by IMP SPECT or the IMP SPECT images were taken after the
administration of steroids. However, statistical mapping revealed the IMP uptake in two of
these four patients. A heterogeneous IMP uptake was seen in homogenous tumors in MRI. For
patients with a hot IMP uptake, statistical mapping showed clearer uptake. The sensitivity and
specificity of original IMP SPECT were 80 and 100% (Chi-test p<0.01), respectively. Those of
statistical mapping were 90 and 100% (Chi-test p<0.01), respectively.
The patients who had received steroid treatment showed negative of IMP SPECT findings.
However, patients with glioma, MS and Burkitt’s lymphoma did not show a high uptake of
delayed IMP SPECT. IMP SPECT is therefore useful for the diagnosis of PCNSL, especially for
the differentiation from glioma, MS and Burkitt’s lymphoma. A heterogeneous IMP uptake
was seen in homogenous tumors in MRI. For patients with a hot IMP uptake, statistical
mapping showed an even clearer uptake. There were some artifacts on the statistical mapping,
however, these artifacts did not result in diagnostic problems due to comparisons of the
statistical mapping and original SPECT or MRI findings.
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Figure 3. 71 Woman: PCNSL
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5. Discussion
5.1. Sensitivity and specificity of IMP SPECT
Our results revealed a high sensitivity (80%) and high specificity (100%) of IMP SPECT in the
diagnosis of PCNSL. Our IMP SPECT of 3.31 mm in pixel size could not detect one small
supratentorial tumor less than 5 mm. Because our patient series included only one patient with
a tumor less than 20 mm in diameter, the detection threshold could not be demonstrated.
However, two cerebellar tumors more than 30 mm in diameter could be detected with the
usual IMP SPECT, while two cerebellar tumors smaller than 25 mm in diameter could not be
detected. Based on our results, the detection threshold of cerebellar tumors seems to be around
25 to 30 mm in diameter.
Akiyama reported that the PCNSL larger than 3 ml could be detected in delayed IMP SPECT
[1]. Their patient series included some patients with brain stem tumors and no patients with
cerebellar tumor. Shinoda reported the IMP SPECT findings in 10 patients with PCNSL [9].
There were two patients with cerebellar tumors in their study, but the tumor size or volume
was not described.
SPECT has some physical and radiological limitations. The absorption of gamma rays in each
tissue decreases the detected signal. Scattering radiation from the gamma ray source leads to
low spatial resolution of the reconstructed SPECT images. The posterior fossa is covered by a
thick area of the skull, so the signal from the brain stem and cerebellum is attenuated more
than that from the cerebrum. Homogeneous attenuation correction could not correct for the
low signal from the posterior fossa. These reasons might underlie the low sensitivity at the
cerebellum. Some methods of correcting the absorption and scattering have been employed,
however, all of these correction methods are associated with some limitations [4]. In our
facility, the scatter was corrected with a Butterworth filter, and the absorption and attenuation
were corrected with the chang method. The chang method assumes homogenous attenuation,
however, the head is not homogenously attenuated. Therefore, using the Chang method leads
to an overestimation of the regional CBF values in IMP SPECT in low CBF regions and an
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underestimation in high CBF regions [4]. The cerebellum is a high CBF region. Therefore, the
tumors at the cerebellum might be less detectable by IMP SPECT than the tumors at the brain
stem.
5.2. Mechanism of IMP uptake
The mechanisms underlying the uptake and retention of IMP in PCNSL are not fully under‐
stood. The amine receptor is one of the IMP binding sites [6]. A specific amine receptor in
PCNSL was hypothesized to be responsible for the IMP retention in PCNSL [10] [11]. Most
IMP binding is considered to be mainly associated with high capacity, relatively nonspecific
binding sites in brain synaptosomes [6]. The IMP SPECT findings suggested that there is strong
IMP binding to PCNSL. In the future, the mechanisms of IMP uptake and the retention in
PCNSL may be revealed by clinical and basic studies of PCNSL.
5.3. Standardization of SPECT images
The CBF is dependent on the patient age. Each patient’s CBF should therefore be evaluated in
comparison with a normal standardized database for specific age groups. Each patient also
has different cerebral morphology. In order to compare the SPECT data of each patient with
the normal standardized database, each patient’s SPECT data should be transformed to fit
standard SPECT data. Using the iNeurostat+ software program, a statistical evaluation of an
anatomically standardized tomographic image is possible. Anatomical standardization and
statistical mapping are useful methods to reduce the differences based on the individual brain
morphology and to objectively evaluate the image findings.
Based on our results, the IMP uptake into PCNSL was highly specific. At present, the final
definite diagnosis of PCNSL should be determined by biopsy and pathological examination.
However, a biopsy is an invasive surgical procedure. Therefore, there is currently no definitive
non-invasive method for diagnosing PCNSL. Some patients, such as those with tumors in the
brain stem, or who are in poor general condition, are not candidates for surgical procedures.
In such cases, IMP SPECT may be helpful to diagnose PCNSL without the surgical risk
associated with a biopsy. Our results warrant further clinical prospective research to evaluate
the clinical significance of IMP SPECT for the diagnosis of PCNSL.
The statistical mapping method was especially useful to detect small tumors that were not
detected using usual IMP SPECT. Statistical mapping has the same spatial resolution as the
original SPECT images. The detectability of tumors at the posterior fossa and skull base is
affected by absorption and scattering corrections. Statistical mapping method reduces these
affects, and as a result, improves the detectability of tumors at the posterior fossa or skull base.
Reconstructed SPECT images include some error and artifacts by nature. A statistical analysis
can reduce some errors and artifacts, however, it can also lead to new errors and artifacts. In
our study, some artifacts were observed in the statistical mapping results that were not seen
in original SPECT images. These artifacts were recognizable as artifacts by comparing the
statistical mapped images with original reconstructed SPECT images. However, it should be
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kept in mind that the statistical mapping images are not original images, and should not be
overrated. The final clinical evaluation should be based on careful image interpretation.
5.4. Study limitations
Our study has some limitations. The patient population was small and selected based on the
criteria of suspected PCNSL. All patients with brain lesions were not included in this study.
However, the patient population in this study represents the actual target population who
need a differential diagnosis. Therefore, this study demonstrated the actual clinical usefulness
of IMP SPECT for the differential diagnosis of PCNSL.
IMP SPECT is useful for the diagnosis of PCNSL because the uptake is specific, as shown in
our results. The gold standard for the diagnosis of PCNSL is the pathological examination of
surgical specimens. There is currently no definitive non-invasive diagnostic method. Because
some patients with PCNSL are contraindicated for surgery, IMP SPECT may represent an
alternative to biopsy for obtaining a diagnosis. Further collection of experiences and improve‐
ments of the diagnostic methods will increase the reliability and decrease the limitations of
diagnostic imaging using IMP SPECT for PCNSL. In the actual clinical diagnosis of PCNSL,
we generally acquire additional information from other examinations, including tumor marker
levels and gallium and/or thallium scintigraphy. In our patient population, we also examined
the findings by these modalities. A detailed discussion of the results of these examinations is
not within the scope of this paper, but such combined evaluations may help overcome some
of the limitations of IMP SPECT.
6. Conclusion
IMP-SPECT and statistical mapping are considered to be useful for the diagnosis of PCNSL.
Multi-modal images should be taken before steroid therapy, because steroids affect the
diagnostic performance of both of MRI and SPECT. Statistical mapping is useful for detecting
small tumors which cannot be detected by usual IMP SPECT. However, some artifacts also
exist in statistical mapping images. The careful interpretation of such image findings is
essential. Anatomical standardized statistical mapping is thus considered a useful method for
improving the diagnostic sensitivity, specificity and accuracy of IMP SPECT for brain lesions.
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